Manufacturer record
Gentech Healthcare Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Gentech Healthcare Pvt Ltd were declared Not of Standard Quality between June 2025 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GLO-002, Povidone Iodine & Metronidazole Solution (IU Liquid) (exp Mar 2027). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay. Listed in the October 2025 alert.
Records by type
3 records linked to Gentech Healthcare Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Povidone Iodine & Metronidazole Solution (IU Liquid) | Batch GLO-002Mfg Apr 2025 · Exp Mar 2027 | The sample does not conform to the IP with respect to Assay.Assay | DTL, JaipurState lab | Oct 2025 |
| Hyoscine Butylbromide & Paracetamol Tablets (Hyofem) | Batch GENT10520Mfg Mar 2025 · Exp Feb 2027 | Assay and DescriptionAssay | DTL, JaipurState lab | Oct 2025 |
| Nexikam-Plus Tablets (Escitalopram Oxalate & Clonazepam Tablets IP) | Batch GENT9932Mfg Dec 2024 · Exp Nov 2026 | Uniformity of Content for both Escitalopram Oxalate & ClonazepamUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.